This contract opportunity involves establishing non-exclusive framework agreements for providing secondary prevention services as per § 43 Abs. 1 Nr. 1 SGB V for the AOK PLUS program "Nutritional Counseling" under an "Open House Model". The services include individual consultations for patients at v
Tender closed on 15 Oct 2025. Awaiting award.
This contract opportunity involves establishing non-exclusive discount agreements for the drug Fampridine, as per German law. The agreements will be made available through an Open House model, allowing all interested pharmaceutical companies to participate if they meet the requirements. There will b
This contract opportunity involves establishing non-exclusive discount agreements for the medication Beclometasone/Formoterol (ATC Code: R03AK08), excluding the dosage of 100µg/6µg as a metered-dose aerosol. The agreements will be made under an Open-House model, allowing all interested pharmaceutica
This contract opportunity involves establishing non-exclusive framework agreements for providing secondary prevention services in accordance with § 43 Abs. 1 Nr. 1 SGB V for the AOK PLUS program "Healthy Back". The services will include conducting courses for patients at various locations in Saxony
This contract opportunity involves establishing non-exclusive discount agreements for pharmaceuticals containing the active ingredients Brinzolamid and Brimonidin (official ATC code: S01EC24) under the German Social Code. The agreements will be made through an Open-House model, allowing all interest
UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.
Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.
Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.
UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.
